Stock listing
Mustang Bio, Inc.
Selected listing: MBIO · BOATS · USD · US
Mustang Bio, Inc. (BOATS:MBIO), Health Technology. Latest release Jul 7, 2025: Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101…
- Ticker
- BOATS:MBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
About Mustang Bio, Inc.
Mustang Bio, Inc. is a public company traded under the ticker MBIO in the American market. Mustang Bio focuses on developing innovative therapies for cancer and rare diseases.
Latest news from Mustang Bio, Inc.
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
July 7, 2025
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
March 5, 2025
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
February 27, 2025
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 10, 2025
Mustang Bio Announces Closing of $8 Million Public Offering
February 9, 2025